Kjetil R.
- Country
- Norway
- Department
- The Lipid Clinic
Research Overview
- Atorvastatin-associated muscle symptoms in adults with familial hypercholesterolaemia: a randomized double-blind n-of-1 crossover trial
- Evaluation of ISIS 678354 Sodium Salt in Patients with Severe Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial
- Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Plozasiran in Adults with Severe Hypertriglyceridemia at High Risk of Acute Pancreatitis (SHASTA-5 Study)
Data & Insights
Has run more than one trial at 71 of 184 partner sites.
Specializations
Metabolic Disorders
The investigator specializes in treating severe hypertriglyceridemia (SHTG), a serious metabolic condition characterized by abnormally high levels of triglycerides in the blood.
- Lipid Metabolism
- Triglyceride Management
- Cardiovascular Risk Reduction
Their research focuses on innovative therapeutic approaches for managing severe lipid disorders.
Clinical Therapeutics
The investigator is involved in evaluating novel therapeutic agents targeting lipid metabolism disorders, with particular emphasis on investigating treatments for patients with severe hypertriglyceridemia.
- Novel Therapeutic Approaches
- Treatment Safety Assessment
- Clinical Efficacy Evaluation
Their work encompasses both safety and efficacy assessments of emerging treatments for metabolic disorders.
Preventive Medicine
The investigator works in the field of preventive cardiology, focusing on managing conditions that contribute to cardiovascular risk through lipid regulation.
- Cardiovascular Risk Prevention
- Metabolic Disease Management
- Long-term Patient Outcomes
Their research contributes to understanding the relationship between lipid disorders and cardiovascular health.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.